Tag: 2026
Merck & Moderna’s Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial
Pharmaceutical giants Merck and Modernarevealed encouraging results from their Phase 3 INTerpath-001 study, testing an individualized mRNA cancer vaccine alongside Merck's immunotherapy drug Keytruda in melanoma patients.
The...
Glenmark Secures U.S. FDA Approval for Flonase®️ Nasal Spray
Glenmark Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluticasone Propionate...
Chai Discovery Collaborates with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery
Chai Discovery has announced a strategic collaboration with Bristol Myers Squibb (BMS) to accelerate AI-powered antibody discovery, moving generative molecular design directly into active...
Massive ₹5 Crore Fake Medicine Scam Uncovered Near Bengaluru
The Drug Enforcement Wing of Karnataka’s Food Safety and Drugs Administration (FSDA), in coordination with local police, has busted a major counterfeit pharmaceutical operation...
Avalon Pharma and Bio-Thera Execute Exclusive Commercialization Agreement for BAT2406 in MENA
Avalon Pharma and Bio-Thera Solutions, Ltd. announced an exclusive licensing and commercialization agreement for BAT2406, a proposed biosimilar referencing Dupixent® (dupilumab), across Saudi Arabia...
Apollo Hospitals Launches ‘Always Open, Always Here’, A Global First in Healthcare From India
Apollo Hospitals has announced the launch of its pioneering initiative, ‘Always Open, Always Here’, making routine, planned, and preventive healthcare services available across all...
